menu
    • menu

    Company profile for HK inno.N

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    inno.N was established in 1984 as CJ CheilJedang Pharmaceutical Business Division, based on 30 years of pharmaceutical business know-how. In 1986, we developed hepatitis prevention vaccine 'Hepaccin-B' with pure domestic technology. We were recognized for our technological capability by mass-producing ‘interferon,’ which was a state-of-the-art basic medicine at that time and 7-ACA, the raw material that requires fine chemi...
    inno.N was established in 1984 as CJ CheilJedang Pharmaceutical Business Division, based on 30 years of pharmaceutical business know-how. In 1986, we developed hepatitis prevention vaccine 'Hepaccin-B' with pure domestic technology. We were recognized for our technological capability by mass-producing ‘interferon,’ which was a state-of-the-art basic medicine at that time and 7-ACA, the raw material that requires fine chemical technology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HK inno.Nkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    (04551) 100, Eulji-ro, Jung-gu, Seoul
    Telephone
    Telephone
    +82-2-6477-0000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.inno-n.com/eng/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    GICELL Announces Collaboration with HK inno.N for next-generation CAR-NK therapy
    GICELL Announces Collaboration with HK inno.N for next-generation CAR-NK therapy

    29 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220829005272/en

    BUSINESSWIRE
    29 Aug 2022
    Share Share
    After $500M IPO, HK inno.N enters exosome drug delivery
    After $500M IPO, HK inno.N enters exosome drug delivery

    31 May 2022

    // Nick Paul Taylor FIERCEPHARMA

    https://www.fiercepharma.com/pharma/after-500m-ipo-hk-innon-enters-exosome-drug-delivery-ilias-pact

    Nick Paul Taylor FIERCEPHARMA
    31 May 2022
    Share Share
    Dr. Reddy's signs multi-country deal for GE in India & Emerging Markets
    Dr. Reddy's signs multi-country deal for GE in India & Emerging Markets

    19 May 2022

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/25/20337/dr-reddys-signs-multi-country-deal-for-gastroenterology-in-india-select-emerging-markets.html

    BIOSPECTRUMASIA
    19 May 2022
    Share Share
    Dr. Reddy’s Laboratories to commercialise novel molecule Tegoprazan in India
    Dr. Reddy’s Laboratories to commercialise novel molecule Tegoprazan in India

    11 May 2022

    // FINANCIAL EXPRESS

    https://www.financialexpress.com/healthcare/pharma-healthcare/dr-reddys-laboratories-to-commercialise-novel-molecule-tegoprazan-in-india/2520304/

    FINANCIAL EXPRESS
    11 May 2022
    Share Share
    K-CAB becomes blockbuster drug topping ?100 billion in annual sales
    K-CAB becomes blockbuster drug topping ?100 billion in annual sales

    17 Jan 2022

    // Lee Han-soo KOREABIOMED

    http://www.koreabiomed.com/news/articleView.html?idxno=12972

    Lee Han-soo KOREABIOMED
    17 Jan 2022
    Share Share

    ABOUT THIS PAGE

    Contact HK inno.N and get a quotation

    HK inno.N is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Tegoprazan bulk offered by HK inno.N

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search